Clinical Trial Update: Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating palifermin for reduction of oral mucositis in patients with hematologic cancers undergoing intensive therapy; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Kepivance (Palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Cancer, Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2014-09-15